Literature DB >> 12632487

HLA-DRB1 allele polymorphisms in genetic susceptibility to esophageal carcinoma.

Jun Lin1, Chang-Sheng Deng, Jie Sun, Xian-Gong Zheng, Xing Huang, Yan Zhou, Ping Xiong, Ya-Ping Wang.   

Abstract

AIM: To probe into the genetic susceptibility of HLA-DRB1 alleles to esophageal carcinoma in Han Chinese in Hubei Province.
METHODS: HLA-DRB1 allele polymorphisms were typed by polymerase chain reaction with sequence-specific primers(PCR-SSP) in 42 unrelated patients with esophageal cancer and 136 unrelated normal control subjects and the associated HLA-DRB1 allele was measured by nucleotide sequence analysis with PCR.SAS software was used in statistics.
RESULTS: Allele frequency (AF) of HLA-DRB1*0901 was significantly higher in esophageal carcinoma patients than that in the normal controls (0.2500 vs 0.1397, P=0.028, the odds ratio 2.053, etiologic fraction 0.1282). After analyzed the allele nucleotide sequence of HLA-DRB1*0901 which approachs to the corresponded exon 2 sequence of the allele in genebank. There was no association between patients and controls in the rested HLA-DRB1 alleles.
CONCLUSION: HLA-DRB1*0901 allele is more common in the patients with esophageal carcinoma than in the healthy controls, which is positively associated with the patients of Hubei Han Chinese. Individuals carrying HLA-DRB1*0901 may be susceptible to esophageal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12632487      PMCID: PMC4621551          DOI: 10.3748/wjg.v9.i3.412

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  54 in total

1.  MHC class I bound peptides of a colon carcinoma cell line, a Ki-ras gene-targeted progeny cell line and a B cell line.

Authors:  C J Savoie; N Kamikawaji; T Sudo; M Furuse; S Shirasawa; T Tana; T Sasazuki
Journal:  Cancer Lett       Date:  1998-01-30       Impact factor: 8.679

2.  Human leukocyte antigens as genetic markers in colorectal carcinoma.

Authors:  M A Chatzipetrou; K E Tarassi; M M Konstadoulakis; H E Pappas; K D Zafirellis; T E Athanassiades; S A Papadopoulos; D G Panousopoulos; B C Golematis; C A Papasteriades
Journal:  Dis Colon Rectum       Date:  1999-01       Impact factor: 4.585

3.  Expression of HLA class II in colorectal cancer: evidence for enhanced immunogenicity of microsatellite-instability-positive tumours.

Authors:  S A Bustin; S R Li; S Phillips; S Dorudi
Journal:  Tumour Biol       Date:  2001 Sep-Oct

4.  HLA class I molecules expression: evaluation of different immunocytochemical methods in malignant lesions.

Authors:  A Facoetti; E Capelli; R Nano
Journal:  Anticancer Res       Date:  2001 Jul-Aug       Impact factor: 2.480

5.  Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer.

Authors:  D Nagorsen; U Keilholz; L Rivoltini; A Schmittel; A Letsch; A M Asemissen; G Berger; H J Buhr; E Thiel; C Scheibenbogen
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

6.  Experimental and clinicopathologic study on the relationship between transcription factor Egr-1 and esophageal carcinoma.

Authors:  M Y Wu; M H Chen; Y R Liang; G Z Meng; H X Yang; C X Zhuang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

7.  Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

Authors:  C Zavaglia; M Martinetti; E Silini; R Bottelli; C Daielli; M Asti; A Airoldi; L Salvaneschi; M U Mondelli; G Ideo
Journal:  J Hepatol       Date:  1998-01       Impact factor: 25.083

8.  Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study.

Authors:  B G Weinshenker; P Santrach; A S Bissonet; S K McDonnell; D Schaid; S B Moore; M Rodriguez
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

9.  In vitro induction of HLA-A2402-restricted and carcinoembryonic-antigen-specific cytotoxic T lymphocytes on fixed autologous peripheral blood cells.

Authors:  C Kim; M Matsumura; K Saijo; T Ohno
Journal:  Cancer Immunol Immunother       Date:  1998-10       Impact factor: 6.968

10.  HLA haplotype sharing in rheumatoid arthritis sibships: risk estimates subdivided by proband genotype.

Authors:  A S Rigby; A J MacGregor; G Thomson
Journal:  Genet Epidemiol       Date:  1998       Impact factor: 2.135

View more
  3 in total

1.  Distribution of HLA Tissue Groups in Patients with Gastric Cancer.

Authors:  Mehmet Bilici; Nihat Okcu; Kerim Cayır; Ibrahim Pirim; Salim B Tekin; Cemal Gundogdu
Journal:  Eurasian J Med       Date:  2010-04

2.  Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B.

Authors:  Ye-Gui Jiang; Yu-Ming Wang; Tong-Hua Liu; Jun Liu
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

3.  Novel genetic locus at MHC region for esophageal squamous cell carcinoma in Chinese populations.

Authors:  Peng Zhang; Xin-Min Li; Xue-Ke Zhao; Xin Song; Ling Yuan; Fang-Fang Shen; Zong-Min Fan; Li-Dong Wang
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.